SouthState Corp’s Biohaven BHVN Stock Holding History

SouthState Corp’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3	Closed	-$46	–	1345
2025 Q3	$46	Hold	3	–	–	﹤0.01%	1325
2025 Q2	$43	Hold	3	–	–	﹤0.01%	1575
2025 Q1	$73	Buy	+3	New	+$106	﹤0.01%	1685

Other funds holding BHVN

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $242M AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SouthState Corp's BHVN Position: Q4 2025 in Review

SouthState Corp sold out of Biohaven (BHVN) in Q4 2025, closing a stake of 3 shares — an estimated $46 sold.

SouthState Corp first reported a position in BHVN in Q1 2025 and held it in 3 quarters. The position peaked at $73 in Q1 2025. 273 funds tracked by Wall St. Rank hold BHVN as of Q4 2025.

SouthState Corp reported no remaining Biohaven position as of Q4 2025 after selling out during the quarter.
SouthState Corp sold 3 Biohaven shares in Q4 2025, an estimated $46.
SouthState Corp first reported a position in Biohaven in Q1 2025 and held it in 3 quarters.
SouthState Corp's Biohaven position peaked at $73 in Q1 2025.
273 funds tracked by Wall St. Rank held Biohaven as of Q4 2025.

Based on SouthState Corp's 13F filing for Q4 2025, filed 11 Feb 2026.